Proteoglycans: Road signs for neurite outgrowth

Neural Regeneration Research

Volumn 9, Issue 4, 2014, Pages 343-355

  Beller, Justin A ^a   Snow, Diane M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Axon outgrowth and regeneration; Chondroitin sulfate proteoglycans; Extracellular matrix; Glial scar; Glycosaminoglycans; Heparan sulfate proteoglycans; Neuronal growth cones; Protein core; Spinal cord injury; Tissue culture

Indexed keywords

BREVICAN; CHONDROITIN ABC LYASE; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MYELIN; NERVE CELL ADHESION MOLECULE; NETRIN; NEUROCAN; NEUROTRANSMITTER; PROTEIN TYROSINE KINASE; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE; SMALL INTERFERING RNA; SYNDECAN 3; TENASCIN; VERSICAN;

ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; EXTRACELLULAR MATRIX; MICROGLIA; NERVE FIBER GROWTH; NERVE REGENERATION; NERVE SPROUTING; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PROTEIN EXPRESSION; SPINAL CORD INJURY; TISSUE REPAIR;

EID: 84897104965     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.128235     Document Type: Article

References (119)

1. Belanger M., Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724-738.
2. Beller J. A, Gurkoff GG, Berman RF, Lyeth BG (2011) Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro. Restor Neurol Neurosci 29:331-346.
3. Beller J. A, Kulengowski B, Kobraei EM, Curinga G, Calulot CM, Bahrami A, Hering TM, Snow DM (2013) Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro. Exp Neurol 247:143-157.
4. Beller J. A, Hering TM, Calulot CM, Snow DM (2014) High-throughput quantitative assay for analyzing neurite outgrowth on a uniform substratum: the cell-substratum assay. In: Neuromethods: Extracellular Matrix (Leach JB, EM Powell, eds). Humana Press, New York (in press).
5. Bespalov M. M, Sidorova YA, Tumova S, Ahonen-Bishopp A, Magalhaes AC, Kulesskiy E, Paveliev M, Rivera C, Rauvala H, Saarma M (2011) Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J Cell Biol 192:153-169.
6. Bovolenta P., Wandosell F, Nieto-Sampedro M (1992) CNS glial scar tissue: a source of molecules which inhibit central neurite outgrowth. Prog Brain Res 94:367-379.
7. Bovolenta P., Fernaud-Espinosa I, Mendez-Otero R, Nieto-Sampedro M (1997) Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies. Eur J Neurosci 9:977-989.
8. Bradbury E. J, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636-640.
9. Bradbury E. J, Carter LM (2011) Manipulating the glial scar: chondroitinase ABC as a therapy for spinal cord injury. Brain Res Bull 84:306-316.
10. Brown J. M, Xia J, Zhuang B, Cho KS, Rogers CJ, Gama CI, Rawat M, Tully S. E, Uetani N, Mason DE, Tremblay ML, Peters EC, Habuchi O, Chen D. F, Hsieh-Wilson LC (2012) A sulfated carbohydrate epitope inhibits axon regeneration after injury. Proc Natl Acad Sci U S A 109:4768-4773.
11. Busch S. A, Horn KP, Cuascut FX, Hawthorne AL, Bai L, Miller RH, Silver J (2010) Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci 30:255-265.
12. Cajal S. R (1892) La retine des vertebres. La Cellule 9:121-133.
13. Campagna J. A, Ruegg MA, Bixby JL (1995) Agrin is a differentiation-inducing "stop signal" for motoneurons in vitro. Neuron 15:1365-1374.
14. Canning D. R, Hoke A, Malemud CJ, Silver J (1996) A potent inhibitor of neurite outgrowth that predominates in the extracellular matrix of reactive astrocytes. Int J Dev Neurosci 14:153-175.
15. Carbonetto S., Gruver MM, Turner DC (1983) Nerve fiber growth in culture on fibronectin, collagen, and glycosaminoglycan substrates. J Neurosci 3:2324-2335.
16. Carulli D., Laabs T, Geller HM, Fawcett JW (2005) Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 15:116-120.
17. Castro C., Kuffler DP (2006) Membrane-bound CSPG mediates growth cone outgrowth and substrate specificity by Schwann cell contact with the DRG neuron cell body and not via growth cone contact. Exp Neurol 200:19-25.
18. Celio M. R, Blumcke I (1994) Perineuronal nets--a specialized form of extracellular matrix in the adult nervous system. Brain Res Brain Res Rev 19:128-145.
19. Chen J., Repunte-Canonigo V, Kawamura T, Lefebvre C, Shin W, Howell LL, Hemby SE, Harvey BK, Califano A, Morales M, Koob GF, Sanna PP (2013) Hypothalamic proteoglycan syndecan-3 is a novel cocaine addiction resilience factor. Nat Commun 4:1955.
20. Chernousov M. A, Carey DJ (1993) N-syndecan (syndecan 3) from neonatal rat brain binds basic fibroblast growth factor. J Biol Chem 268:16810-16814.
21. Cho J. Y, Chak K, Andreone BJ, Wooley JR, Kolodkin AL (2012) The extracellular matrix proteoglycan perlecan facilitates transmembrane semaphorin-mediated repulsive guidance. Genes Dev 26:2222-2235.
22. Cole G. J, McCabe CF (1991) Identification of a developmentally regulated keratan sulfate proteoglycan that inhibits cell adhesion and neurite outgrowth. Neuron 7:1007-1018.
23. Coles C. H, Shen Y, Tenney AP, Siebold C, Sutton GC, Lu W, Gallagher JT, Jones EY, Flanagan JG, Aricescu AR (2011) Proteoglycan-specific molecular switch for RPTPsigma clustering and neuronal extension. Science 332:484-488.
24. Condic M. L, Snow DM, Letourneau PC (1999) Embryonic neurons adapt to the inhibitory proteoglycan aggrecan by increasing integrin expression. J Neurosci 19:10036-10043.
25. Cox T. R, Erler JT (2011) Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4:165-178.
26. Curinga G., Snow DM, Smith GM (2008) Mechanisms regulating interpretation of guidance cues during development, maturation, and following injury. Rev Neurosci 19:213-226.
27. DeLuca S., Richmond ME, Silbert JE (1973) Biosynthesis of chondroitin sulfate. Sulfation of the polysaccharide chain. Biochemistry 12:3911-3915.
28. Dickendesher T. L, Baldwin KT, Mironova YA, Koriyama Y, Raiker SJ, Askew K. L, Wood A, Geoffroy CG, Zheng B, Liepmann CD, Katagiri Y, Benowitz L. I, Geller HM, Giger RJ (2012) NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat Neurosci 15:703-712.
29. Doretto S., Malerba M, Ramos M, Ikrar T, Kinoshita C, De Mei C, Tirotta E., Xu X, Borrelli E (2011) Oligodendrocytes as regulators of neuronal networks during early postnatal development. PLoS One 6:e19849.
30. Dou C. L, Levine JM (1994) Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J Neurosci 14:7616-7628.
31. Dou C. L, Levine JM (1997) Identification of a neuronal cell surface receptor for a growth inhibitory chondroitin sulfate proteoglycan (NG2). J Neurochem 68:1021-1030.
32. Fawcett J. W, Asher RA (1999) The glial scar and central nervous system repair. Brain Res Bull 49:377-391.
33. Fernaud-Espinosa I., Nieto-Sampedro M, Bovolenta P (1994) Differential effects of glycosaminoglycans on neurite outgrowth from hippocampal and thalamic neurones. J Cell Sci 107:1437-1448.
34. Fidler P. S, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH, Faissner A, Fawcett JW (1999) Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19:8778-8788.
35. Fitch M. T, Silver J (2008) CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 209:294-301.
36. Franco S. J, Muller U (2011) Extracellular matrix functions during neuronal migration and lamination in the mammalian central nervous system. Dev Neurobiol 71:889-900.
37. Frantz C., Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123:4195-4200.
38. Friedlander D. R, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M (1994) The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 125:669-680.
39. Galtrey C. M, Fawcett JW (2007) The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 54:1-18.
40. Garcia-Alias G., Barkhuysen S, Buckle M, Fawcett JW (2009) Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci 12:1145-1151.
41. Garwood J., Schnadelbach O, Clement A, Schutte K, Bach A, Faissner A (1999) DSD-1-proteoglycan is the mouse homolog of phosphacan and displays opposing effects on neurite outgrowth dependent on neuronal lineage. J Neurosci 19:3888-3899.
42. Garwood J., Heck N, Reichardt F, Faissner A (2003) Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth. J Biol Chem 278:24164-24173.
43. Gilbert R. J, McKeon RJ, Darr A, Calabro A, Hascall VC, Bellamkonda RV (2005) CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension. Mol Cell Neurosci 29:545-558.
44. Habuchi H., Habuchi O, Kimata K (2004) Sulfation pattern in glycosaminoglycan: does it have a code? Glycoconj J 21:47-52.
45. Hantaz-Ambroise D., Vigny M, Koenig J (1987) Heparan sulfate proteoglycan and laminin mediate two different types of neurite outgrowth. J Neurosci 7:2293-2304.
46. Hardingham T. E, Fosang AJ (1992) Proteoglycans: many forms and many functions. FASEB J 6:861-870.
47. Harris A. J (1999) Cortical origin of pathological pain. Lancet 354, 1464-1466.
48. Hartmann U., Maurer P (2001) Proteoglycans in the nervous system--the quest for functional roles in vivo. Matrix Biol 20:23-35.
49. Haydon P. G, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009-1031.
50. Holt C. E, Dickson BJ (2005) Sugar codes for axons? Neuron 46:169-172.
51. Hu R., Zhou J, Luo C, Lin J, Wang X, Li X, Bian X, Li Y, Wan Q, Yu Y, Feng H. (2010) Glial scar and neuroregeneration: histological, functional, and magnetic resonance imaging analysis in chronic spinal cord injury. J Neurosurg Spine 13:169-180.
52. Huang W. C, Kuo WC, Cherng JH, Hsu SH, Chen PR, Huang SH, Huang MC, Liu JC, Cheng H (2006) Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Biophys Res Commun 349:963-968.
53. Hynds D. L, Snow DM (2002) A semi-automated image analysis method to quantify neurite preference/axon guidance on a patterned substratum. J Neurosci Methods 121:53-64.
54. Iijima N., Oohira A, Mori T, Kitabatake K, Kohsaka S (1991) Core protein of chondroitin sulfate proteoglycan promotes neurite outgrowth from cultured neocortical neurons. J Neurochem 56:706-708.
55. Inatani M., Honjo M, Otori Y, Oohira A, Kido N, Tano Y, Honda Y, Tanihara H. (2001) Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest Ophthalmol Vis Sci 42:1930-1938.
56. Jander S., Stoll G (1996) Strain-specific expression of microglial keratan sulfate proteoglycans in the normal rat central nervous system: inverse correlation with constitutive expression of major histocompatibility complex class II antigens. Glia 18:255-260.
57. Jones L. L, Yamaguchi Y, Stallcup WB, Tuszynski MH (2002) NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 22:2792-2803.
58. Jones L. L, Margolis RU, Tuszynski MH (2003) The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 182:399-411.
59. Jones L. L, Sajed D, Tuszynski MH (2003) Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 23:9276-9288.
60. Jourdain P., Bergersen LH, Bhaukaurally K, Bezzi P, Santello M, Domercq M, Matute C, Tonello F, Gundersen V, Volterra A (2007) Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci 10:331-339.
61. Kaneko M., Kubo T, Hata K, Yamaguchi A, Yamashita T (2007) Repulsion of cerebellar granule neurons by chondroitin sulfate proteoglycans is mediated by MAPK pathway. Neurosci Lett 423:62-67.
62. Karumbaiah L., Anand S, Thazhath R, Zhong Y, McKeon RJ, Bellamkonda RV (2011) Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition. Glia 59:981-996.
63. Kastenhuber E., Kern U, Bonkowsky JL, Chien CB, Driever W, Schweitzer J (2009) Netrin-DCC, Robo-Slit, and heparan sulfate proteoglycans coordinate lateral positioning of longitudinal dopaminergic diencephalospinal axons. J Neurosci 29:8914-8926.
64. Kim M. J, Cotman SL, Halfter W, Cole GJ (2003) The heparan sulfate proteoglycan agrin modulates neurite outgrowth mediated by FGF-2. J Neurobiol 55:261-277.
65. Kinnunen A., Kinnunen T, Kaksonen M, Nolo R, Panula P, Rauvala H (1998) N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. Eur J Neurosci 10:635-648.
66. Kinnunen T., Raulo E, Nolo R, Maccarana M, Lindahl U, Rauvala H (1996) Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem 271:2243-2248.
67. Kinnunen T., Kaksonen M, Saarinen J, Kalkkinen N, Peng HB, Rauvala H (1998) Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem 273:10702-10708.
68. Krull C. E, Oland LA, Faissner A, Schachner M, Tolbert LP (1994) In vitro analyses of neurite outgrowth indicate a potential role for tenascin-like molecules in the development of insect olfactory glomeruli. J Neurobiol 25:989-1004.
69. Lander A. D, Fujii DK, Gospodarowicz D, Reichardt LF (1982) Characterization of a factor that promotes neurite outgrowth: evidence linking activity to a heparan sulfate proteoglycan. J Cell Biol 94:574-585.
70. Lander C., Zhang H, Hockfield S (1998) Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J Neurosci 18:174-183.
71. Lauri S. E, Kaukinen S, Kinnunen T, Ylinen A, Imai S, Kaila K, Taira T, Rauvala H. (1999) Regulatory role and molecular interactions of a cell-surface heparan sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J Neurosci 19:1226-1235.
72. Lemons M. L, Barua S, Abanto ML, Halfter W, Condic ML (2005) Adaptation of sensory neurons to hyalectin and decorin proteoglycans. J Neurosci 25:4964-4973.
73. Letourneau P. C, Condic ML, Snow DM (1994) Interactions of developing neurons with the extracellular matrix. J Neurosci 14:915-928.
74. Lu P., Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3.
75. Lukes A., Mun-Bryce S, Lukes M, Rosenberg GA (1999) Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol 19:267-284.
76. Mack A. F, Wolburg H (2013) A novel look at astrocytes: aquaporins, ionic homeostasis, and the role of the microenvironment for regeneration in the CNS. Neuroscientist 19:195-207.
77. Maeda N., Noda M (1996) 6B4 proteoglycan/phosphacan is a repulsive substratum but promotes morphological differentiation of cortical neurons. Development 122:647-658.
78. Massey J. M, Hubscher CH, Wagoner MR, Decker JA, Amps J, Silver J, Onifer S. M (2006) Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci 26:4406-4414.
79. Matsuo I., Kimura-Yoshida C (2013) Extracellular modulation of Fibroblast Growth Factor signaling through heparan sulfate proteoglycans in mammalian development. Curr Opin Genet Dev. 23:399-407.
80. McKeon R. J, Hoke A, Silver J (1995) Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 136:32-43.
81. Milev P., Friedlander DR, Sakurai T, Karthikeyan L, Flad M, Margolis RK, Grumet M, Margolis RU (1994) Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127:1703-1715.
82. Nakanishi K., Aono S, Hirano K, Kuroda Y, Ida M, Tokita Y, Matsui F, Oohira A. (2006) Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J Biol Chem 281:24970-24978.
83. Niederost B. P, Zimmermann DR, Schwab ME, Bandtlow CE (1999) Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci 19:8979-8989.
84. Nishizuka M., Ikeda S, Arai Y, Maeda N, Noda M (1996) Cell surface-associated extracellular distribution of a neural proteoglycan, 6B4 proteoglycan/ phosphacan, in the olfactory epithelium, olfactory nerve, and cells migrating along the olfactory nerve in chick embryos. Neurosci Res 24:345-355.
85. Oohira A., Matsui F, Katoh-Semba R (1991) Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells. J Neurosci 11:822-827.
86. Perea G., Navarrete M, Araque A (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32:421-431.
87. Pizzorusso T., Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L (2002) Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298:1248-1251.
88. Poole A. R (1986) Proteoglycans in health and disease: structures and functions. Biochem J 236:1-14.
89. Pyka M., Wetzel C, Aguado A, Geissler M, Hatt H, Faissner A (2011) Chondroitin sulfate proteoglycans regulate astrocyte-dependent synaptogenesis and modulate synaptic activity in primary embryonic hippocampal neurons. Eur J Neurosci 33:2187-2202.
90. Rolls A., Shechter R, Schwartz M (2009) The bright side of the glial scar in CNS repair. Nat Rev Neurosci 10:235-241.
91. Rudge J. S, Silver J (1990) Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10:3594-3603.
92. Schmalfeldt M., Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR (2000) Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113: 807-816.
93. Shen Y., Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K, He Z, Silver J, Flanagan J. G (2009) PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326:592-596.
94. Shioi J., Pangalos MN, Ripellino JA, Vassilacopoulou D, Mytilineou C, Margolis R. U, Robakis NK (1995) The Alzheimer amyloid precursor proteoglycan (appican) is present in brain and is produced by astrocytes but not by neurons in primary neural cultures. J Biol Chem 270:11839-11844.
95. Shortland P., Kinman E, Molander C (1997) Sprouting of A-fibre primary afferents into lamina II in two rat models of neuropathic pain. Eur J Pain 1:215-227.
96. Smith-Thomas L. C, Stevens J, Fok-Seang J, Faissner A, Rogers JH, Fawcett JW (1995) Increased axon regeneration in astrocytes grown in the presence of proteoglycan synthesis inhibitors. J Cell Sci 108:1307-1315.
97. Snow D. M, Lemmon V, Carrino DA, Caplan AI, Silver J (1990) Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 109:111-130.
98. Snow D. M, Letourneau PC (1992) Neurite outgrowth on a step gradient of chondroitin sulfate proteoglycan (CS-PG). J Neurobiol 23:322-336.
99. Snow D. M, Atkinson PB, Hassinger TD, Letourneau PC, Kater SB (1994) Chondroitin sulfate proteoglycan elevates cytoplasmic calcium in DRG neurons. Dev Biol 166:87-100.
100. Snow D. M, Brown EM, Letourneau PC (1996) Growth cone behavior in the presence of soluble chondroitin sulfate proteoglycan (CSPG), compared to behavior on CSPG bound to laminin or fibronectin. Int J Dev Neurosci 14:331-349.
101. Snow D. M, Mullins N, Hynds DL (2001) Nervous system-derived chondroitin sulfate proteoglycans regulate growth cone morphology and inhibit neurite outgrowth: a light, epifluorescence, and electron microscopy study. Microsc Res Tech 54:273-286.
102. Snow D. M (2011) Pioneering studies on the mechanisms of axonal regeneration. Dev Neurobiol 71:785-789.
103. Sofroniew M. V (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11:400-407.
104. Tang X., Davies JE, Davies SJ (2003). Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 71:427-444.
105. Tauchi R., Imagama S, Natori T, Ohgomori T, Muramoto A, Shinjo R, Matsuyama Y., Ishiguro N, Kadomatsu K (2012) The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. J Neuroinflammation 9:53.
106. Tkachenko E., Rhodes JM, Simons M (2005) Syndecans: new kids on the signaling block. Circ Res 96:488-500.
107. Tom V. J, Steinmetz MP, Miller JH, Doller CM, Silver J (2004) Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci 24:6531-6539.
108. Tom V. J, Kadakia R, Santi L, Houle JD (2009) Administration of chondroitinase ABC rostral or caudal to a spinal cord injury site promotes anatomical but not functional plasticity. J Neurotrauma 26:2323-2333.
109. Treloar H. B, Ray A, Dinglasan LA, Schachner M, Greer CA (2009) Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb. J Neurosci 29:9405-9416.
110. Verna J. M, Fichard A, Saxod R (1989) Influence of glycosaminoglycans on neurite morphology and outgrowth patterns in vitro. Int J Dev Neurosci 7:389-399.
111. Wake H., Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29:3974-3980.
112. Wang D., Fawcett J (2012). The perineuronal net and the control of CNS plasticity. Cell Tissue Res 349:147-160.
113. Wang H., Katagiri Y, McCann TE, Unsworth E, Goldsmith P, Yu ZX, Tan F, Santiago L, Mills EM, Wang Y, Symes AJ, Geller HM (2008) Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J Cell Sci 121:3083-3091.
114. Wu Y., Sheng W, Chen L, Dong H, Lee V, Lu F, Wong CS, Lu WY, Yang BB (2004) Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 15:2093-2104.
115. Yamada H., Fredette B, Shitara K, Hagihara K, Miura R, Ranscht B, Stallcup W. B, Yamaguchi Y (1997) The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J Neurosci 17:7784-7795.
116. Yanagishita M. (1993) A brief history of proteoglycans. Experientia 49:366-368.
117. Yu P., Pisitkun T, Wang G, Wang R, Katagiri Y, Gucek M, Knepper MA, Geller H. M (2013) Global analysis of neuronal phosphoproteome regulation by chondroitin sulfate proteoglycans. PLoS One 8:e59285.
118. Zhang J. M, Li H, Munir MA (2004) Decreasing sympathetic sprouting in pathologic sensory ganglia: a new mechanism for treating neuropathic pain using lidocaine. Pain 109:143-149.
119. Zimmermann M. (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429:23-37.